German breast cancer DMP (disease management programme) backed by Schmidt:
This article was originally published in Clinica
Executive Summary
A new disease management programme (DMP) for the treatment of breast cancer in the German federal state of Baden-Wurrtemberg has received the tacit support of federal health minister Ulla Schmidt. The DMP, the result of an agreement between the Baden-Wurrtemberg hospitals' association, health insurance funds and doctors' association, focuses on offering treatment according to internationally accepted medical guidelines and standards. Ms Schmidt said that the opening of hospitals for outpatient treatment would play an important role in breast cancer care. The federal insurance department, which approves DMPs, has so far given the go-ahead for 186 programmes.
You may also be interested in...
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.